DDAR News

Message to Our Patients

Dear Patients
 
We are waiting for additional direction from the Governor's Office, CDC and Local Regulatory Authorities to reopen our office for elective procedures and non-urgent patient visits. We anticipate that in the not to distance future, we will get the green light to begin performing those non-urgent procedures which were cancelled or deferred over the past few months.
 
Rest assured that we will continue to exercise the utmost caution to ensure your safety!  We will continue to pre-screen all patients for their Covid-19 risk and stagger our schedules so that we minimize potential exposures.  Until that time, we continue to be available to you for telehealth visits, urgent procedures and essential infusions.   Please remember that we are just a phone call away.
 
On behalf of the Physicians and Staff at Digestive Disease Associates of Rockland, please stay safe and we look forward to seeing you again in the near future!
 
Sincerely
 
Elliot A Heller MD
President

We Are Open & Available

Dear Patients

Your Digestive Disease Associates of Rockland Physicians and Nurse Practitioners are here to serve you and can now provide care via telehealth from the comfort and safety of your home.  Please call our office at 845-354-3700 and select option 3 to speak to our secretarial staff.  Same day telehealth appointments are available. Urgent and Emergent Office Appointments are also available  

 Please Stay Safe!

 Sincerely,

 Drs. Heller, Moccia, Goldenberg, Hollander, Shah, Sara, Langman, Debbie Caputo and Jennifer Poterbin

Coronavirus COVID-19 Preparations

Dear Patients

We are preparing like most of the other medical offices in the community to deal with a Coronavrus (COVID-19) threat.  We are currently calling all patients prior to their scheduled procedures & office visits to ascertain their health status. We are providing special accommodations for patients on immunosuppressant medications.  We are querying all patients, escorts and guests as they come to the office for fevers and other flu-like symptoms and advising them to wear masks. To date, we do not have any known or suspected cases amongst our staff and amongst our established patients. 

We are doing aggressive disinfection of all of the equipment, furniture and surfaces throughout the day and every evening.  Lastly, we are exploring the possibility of introducing tele-medical consults for our established patients, if there is an outbreak or large cluster of cases occurs in our area.  

Please rest assure that we will be everything possible to ensure that we are ready to provide you with uninterrupted care.

Sincerely

 

Elliot A Heller MD                                                                                                                                                                                                                                                                                             

Non-Alcoholic Steatohepatitis (NASH) Trial

Non-Alcoholic Steatohepatitis (NASH) Trial 

Digestive Disease Associates of Rockland and Gen1 Research have partnered in a study evaluating an investigational drug for treatment of liver fibrosis in adult patients who have non-alcoholic steatohepatitis (NASH).  To qualify, participants must:

 

  • Be between the ages if 18 and 75
  • Have had liver biopsy or be willing to undergo a liver biopsy

 Qualified participants may receive:

 

  • Compensation for time & travel
  • Study-related care at no cost

 For more information, please contact our Clinical Research Coordinator, Samantha Oberdier, at (845) 367-1621 or soberdier@gen1research.com

Pages

DDAR Blog

5/12/20

Small Intestinal Bacterial Overgrowth

What is SIBO?

Small Intestine Bacterial Overgrowth (SIBO) is a chronic bacterial infection of the small intestine.  The infection is of...

Latest News

5/12/20
Dear Patients   We are waiting for additional direction from the Governor's Office, CDC and Local Regulatory Authorities to reopen our office for elective procedures and non-urgent patient visits. We...